Neutron studies of HIV inhibitors reveal new areas for improvement in drug design to enhance performance, combat resista
The first study of interactions between a common clinical inhibitor and the HIV-1 protease enzyme has been carried out by an international team with members from the US, Britain and France using neutrons at the Institut Laue-Langevin ...